JPMORGAN CHASE & CO

Position in CAPR — Capricor Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in CAPR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$8,729,022

-$1,716,811 QoQ

Shares Held

362,501

+5.5% QoQ

Ownership

0.624%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 170 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. CAPR ranks #94 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,729,022	362,501	+5.5%	Shares	Other	2026-08-12
2026-03-31	$10,445,833	343,613	-6.9%	Shares	Defined	2026-05-13
2025-12-31	$10,653,205	369,134	+94.5%	Shares	Defined	2026-02-11
2025-09-30	$1,368,448	189,799	-2.8%	Shares	Defined	2025-11-07
2025-06-30	$1,938,225	195,189	+1020.2%	Shares	Defined	2025-08-12
2025-03-31	$165,362	17,425	+4.5%	Shares	Defined	2025-05-12
2024-12-31	$230,183	16,680	-70.3%	Shares	Defined	2025-02-12
2024-09-30	$854,785	56,199	+419.5%	Shares	Defined	2024-12-26
2024-06-30	$51,601	10,818	-88.1%	Shares	Defined	2024-12-26
2024-03-31	$618,453	91,083	+118189.6%	Shares	Defined	2024-12-26
2021-06-30	$395	77	-98.6%	Shares	Defined	2021-08-12
2020-09-30	$29,436	5,607	+80000.0%	Shares	Defined	2020-11-12
2020-06-30	$32	7	—	Shares	Defined	2020-08-11
No filing history on record for this holder in this stock.